Tag:
Chi-Med
Latest Headlines
Latest Headlines
AZ commits $140M to cancer pact as it inks back-to-back deals
A day after AstraZeneca ( $AZN ) managed to raise fresh doubts about its ability to efficiently develop new therapies with twin setbacks in the clinic, the pharma company is back with a pair of new
Chinese drugmaker could partner with Abbott
Hutchison China MediTech, or Chi-Med, the pharmaceutical company controlled by Hong Kong billionaire Li Ka-shing, is looking for a partner this year for its experimental treatment for a bowel
